Kelvin Lin is an associate in Goodwin’s Technology Companies and Life Sciences groups. His practice consists of general corporate and securities law, with a focus on venture capital financings, mergers and acquisitions, SEC compliance and corporate governance. Mr. Lin advises public and private emerging growth technology and life science companies throughout their life cycle from formation to equity financings, and to exit. Mr. Lin also advises pharmaceutical companies, venture capital funds and investment banks. He joined Goodwin in 2017.

Areas of Practice
Domaines D’Expertise





Representative Matters



Venture Financings
  • SmileDirectClub in its $380 million preferred equity financing
  • HOOKIPA Pharma in its Series D financing
  • A banking consortium in the Series B financing of a market-leading blockchain platform for the global financial markets
  • TARA Biosystems in its Series A financing
  • ClaimKit, Inc. in its Series B financing
Mergers & Acquisitions
  • Amplify Snack Brands in a $1.6 billion merger with The Hershey Company
  • Mediamorph in its sale to TV Time
  • Updater in its acquisition of Bridgevine
  • Divestiture of rights to commercialize a drug in 55 countries to a Spanish biopharmaceutical company
  • Sale of a branded generic drug in the U.S.
  • PointClickCare in its acquisition of COMS Interactive
Capital Markets
  • Axon Enterprise in its $262 million public follow-on offering
  • Vericel Corporation in its $74.8 million public follow-on offering
  • SVB Leerink and Evercore Group in Centogene B.V.’s $56 million initial public offering
  • The underwriters in PhaseBio’s $46 million initial public offering
  • The underwriters in follow-on offerings for Viking Therapeutics, Oncocyte, Zogenix, Ovid Therapeutics, Synlogic, and Dare Biosciences


While attending law school, Mr. Lin served as the executive editor for Columbia Law’s Journal of Law and Social Problems. He was also a member of the Mediation Clinic and was a student body representative on Columbia Law’s Student Senate as well as the law school representative for the Interschool Governing Board.

In The News









J.D., 2017
Columbia Law School
(Harlan Fiske Stone Scholar)
B.A., 2014
Cornell University
(Dean's List)



New York
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique